BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 28261958)

  • 1. Rate of positive autoimmune markers in Human T lymphotropic virus type 1 carriers: a case-control study from Iran.
    Ahmadi Ghezeldasht S; Hedayati-Moghaddam MR; Habibi M; Mollahosseini F; Rafatpanah H; Miri R; Hatef Fard M; Sahebari M
    Int J Rheum Dis; 2018 Jan; 21(1):108-113. PubMed ID: 28261958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HTLV-1 seroprevalance in sarcoidosis. A clinical and laboratory study in northeast of Iran.
    Saghafi M; Rezaieyazdi Z; Nabavi S; Mirfeizi Z; Sahebari M; Salari M
    Int J Rheum Dis; 2018 Jun; 21(6):1309-1313. PubMed ID: 28185411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Status of humoral and cellular immune markers in human T-cell lymphotropic virus type 1 (HTLV-1) asymptomatic carriers in northeastern Iran, Mashhad.
    Hedayati-Moghaddam MR; Mollahosseini F; Namazi MJ; Mosavat A; Rezaee SA; Mahdifar M; Bidkhori HR; Valizadeh N; Rafatpanah H
    J Neurovirol; 2020 Dec; 26(6):863-869. PubMed ID: 33025348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Tax antibody levels in asymptomatic carriers, oligosymptomatic carriers, patients with rheumatologic disease or with HAM/TSP do not correlate with HTLV-1 proviral load.
    de Souza JG; da Fonseca FG; Martins ML; Martins CP; de Carvalho LD; Coelho-dos-Reis JG; Carneiro-Proietti AB; Martins-Filho OA; Barbosa-Stancioli EF;
    J Clin Virol; 2011 Jan; 50(1):13-8. PubMed ID: 20951636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroepidemiology of human T-cell lymphotropic virus 1 infection in hemodialysis patients: should we be concerned about it?
    Ghaffari J; Ebrahimi M; Makhlough A; Mohammadjafari H; Nazari Z
    Iran J Kidney Dis; 2013 May; 7(3):187-90. PubMed ID: 23689148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population differences in immune marker profiles associated with human T-lymphotropic virus type I infection in Japan and Jamaica.
    Birmann BM; Breen EC; Stuver S; Cranston B; Martínez-Maza O; Falk KI; Okayama A; Hanchard B; Mueller N; Hisada M
    Int J Cancer; 2009 Feb; 124(3):614-21. PubMed ID: 18989900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
    Kozako T; Yoshimitsu M; Akimoto M; White Y; Matsushita K; Soeda S; Shimeno H; Kubota R; Izumo S; Arima N
    Hum Immunol; 2011 Nov; 72(11):1001-6. PubMed ID: 21851845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Autoimmune syndrome in the tropical spastic paraparesis/myelopathy associated with human T-lymphotropic virus infections].
    Domínguez MC; Torres M; Tamayo O; Criollo W; Quintana M; Sánchez A; García F
    Biomedica; 2008 Dec; 28(4):510-22. PubMed ID: 19462556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of HTLV-I with autoimmune thyroiditis in patients with adult T-cell leukaemia (ATL) and in HTLV-I carriers.
    Akamine H; Takasu N; Komiya I; Ishikawa K; Shinjyo T; Nakachi K; Masuda M
    Clin Endocrinol (Oxf); 1996 Oct; 45(4):461-6. PubMed ID: 8959086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antinuclear autoantibodies in human T-cell leukemia/lymphoma virus type I carriers in French Guiana.
    Talarmin A; Nizou JY; Kazanji M
    Arch Virol; 1997; 142(8):1713-8. PubMed ID: 9672631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human T-Lymphotropic Virus Type I (HTLV-1) Infection among Iranian Blood Donors: First Case-Control Study on the Risk Factors.
    Hedayati-Moghaddam MR; Tehranian F; Bayati M
    Viruses; 2015 Nov; 7(11):5736-45. PubMed ID: 26556363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative proviral DNA and antibody levels in the natural history of HTLV-I infection.
    Manns A; Miley WJ; Wilks RJ; Morgan OS; Hanchard B; Wharfe G; Cranston B; Maloney E; Welles SL; Blattner WA; Waters D
    J Infect Dis; 1999 Nov; 180(5):1487-93. PubMed ID: 10515807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HTLV-1, Immune Response and Autoimmunity.
    Quaresma JA; Yoshikawa GT; Koyama RV; Dias GA; Fujihara S; Fuzii HT
    Viruses; 2015 Dec; 8(1):. PubMed ID: 26712781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
    Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
    J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for adult T-cell leukemia among carriers of human T-lymphotropic virus type I.
    Hisada M; Okayama A; Shioiri S; Spiegelman DL; Stuver SO; Mueller NE
    Blood; 1998 Nov; 92(10):3557-61. PubMed ID: 9808547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of glutathione intracellular levels alters the spontaneous proliferation of lymphocyte from HTLV-1 infected patients.
    Novaes R; Freire-de-Lima CG; de Albuquerque RC; Affonso-Mitidieri OR; Espindola O; Lima MA; de Andrada Serpa MJ; Echevarria-Lima J
    Immunobiology; 2013 Sep; 218(9):1166-74. PubMed ID: 23669236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human T-lymphotropic virus type 1 prevalence in northeastern Iran, Sabzevar: an epidemiologic-based study and phylogenetic analysis.
    Azarpazhooh MR; Hasanpour K; Ghanbari M; Rezaee SA; Mashkani B; Hedayati-Moghaddam MR; Valizadeh N; Farid Hosseini R; Foroghipoor M; Soltanifar A; Sahebari M; Azadmanesh K; Hassanshahi G; Rafatpanah H
    AIDS Res Hum Retroviruses; 2012 Sep; 28(9):1095-1101. PubMed ID: 22229796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human T cell lymphotropic virus (HTLV) type-1-specific CD8+ T cells: frequency and immunodominance hierarchy.
    Goon PK; Biancardi A; Fast N; Igakura T; Hanon E; Mosley AJ; Asquith B; Gould KG; Marshall S; Taylor GP; Bangham CR
    J Infect Dis; 2004 Jun; 189(12):2294-8. PubMed ID: 15181578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological signature of the different clinical stages of the HTLV-1 infection: establishing serum biomarkers for HTLV-1-associated disease morbidity.
    Starling AL; Coelho-Dos-Reis JG; Peruhype-Magalhães V; Pascoal-Xavier MA; Gonçalves DU; Béla SR; Lambertucci JR; Labanca L; Souza Pereira SR; Teixeira-Carvalho A; Ribas JG; Trindade BC; Faccioli LH; Carneiro-Proietti AB; Martins-Filho OA
    Biomarkers; 2015; 20(6-7):502-12. PubMed ID: 26474234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroepidemiology of human T-cell lymphotropic virus type-1 (HTLV1) in Mashhad.
    Safabakhsh H; Jalalian M; Karimi G
    Glob J Health Sci; 2014 May; 6(5):99-104. PubMed ID: 25168999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.